ALHC — Alignment Healthcare, Inc.

Alignment Healthcare, Inc. (ALHC) Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics:

• Health Plan Membership: 284,800, a 31% increase year-over-year.
• Total Revenue: $1.2 billion, up 33% year-over-year.
• Adjusted Gross Profit: $146 million, with a Medical Benefit Ratio (MBR) of 88.2%, improving by 20 basis points year-over-year.
• Adjusted SG&A: $108 million, representing 8.7% of revenue, a 60 basis points improvement year-over-year.
• Adjusted EBITDA: $38 million, an 88% increase year-over-year, with a margin of 3.1%.

2. Strategic Updates and Business Highlights:

• Strong execution in sales and member retention contributed to membership growth.
• The company is focused on scaling operations and improving clinical efficiencies, including significant advancements in claims automation (from 15% to over 60% auto adjudication).
• Investments in AI for contract management and clinical engagement are underway to enhance operational efficiency.
• The company expressed confidence in achieving its long-term goal of reaching 1 million members.
• Positive response to the 2027 final rate notice, with expectations that Medicare Advantage remains a durable program.

3. Forward Guidance and Outlook:

• Full Year 2026 Guidance:
  • Membership expected between 294,000 and 299,000.
  • Revenue projected at $5.16 billion to $5.21 billion.
  • Adjusted gross profit between $620 million and $650 million.
  • Adjusted EBITDA forecasted between $138 million and $163 million.
• Q2 2026 Expectations:
  • Membership between 288,000 and 290,000.
  • Revenue between $1.30 billion and $1.32 billion.
  • Adjusted gross profit between $167 million and $177 million.
  • Adjusted EBITDA between $50 million and $60 million.
• The company raised its membership and revenue growth expectations due to strong sales and retention.

4. Bad News, Challenges, or Points of Concern:

• A temporary issue with inpatient admissions due to a CMS rule change impacted Q1 results, leading to higher-than-expected inpatient admissions per 1,000.
• The company does not expect to recover additional reimbursements for the overpayments made during the issue.
• Increased focus on higher-acuity populations may lead to higher inpatient admissions, which could pressure margins.
• The company remains cautious regarding risk adjustment for new members, indicating potential variability in future performance metrics.

5. Notable Q&A Insights:

• Management confirmed that the inpatient admission issue was an internal workflow problem, resolved quickly, and not indicative of systemic issues.
• There is ongoing caution regarding risk adjustment for new members, with expectations of potential upside in the second quarter.
• The company is exploring in-house management of supplemental benefits to improve cost profiles and reduce MLR.
• Discussions around the competitive landscape indicate a belief that Medicare Advantage plans should focus on delivering value rather than engaging in competitive pricing strategies.
• The company is considering expansion into new markets while ensuring operational frameworks can support growth.

Overall, Alignment Healthcare demonstrated strong financial performance in Q1 2026, with positive growth metrics and strategic initiatives aimed at enhancing operational efficiency and member engagement. However, challenges related to inpatient admissions and cautious optimism regarding new member risk adjustments highlight areas for continued focus.